CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CSPC Pharmaceutical Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CSPC Pharmaceutical Group Ltd
No. 226 Huanghe Avenue
Phone: +86 31187037015p:+86 31187037015 SHIJIAZHUANG, HEB  050035  China Ticker: 10931093
Business Summary
CSPC Pharmaceutical Group Ltd is an investment holding company primarily engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board DongchenCai 70 5/27/2022 1/1/1998
Executive Vice Chairman of the Board, Chief Executive Officer CuilongZhang 55 5/27/2022 7/9/2018
Executive Director XinCai 33 5/28/2024 5/28/2024
12 additional Officers and Directors records available in full report.

Business Names
Business Name
1093
China Pharmaceutical Enterprise & Inv.
China Pharmaceutical Group Limited
CHJTF
CHPTY
CSPC shengxue glucose co., ltd.

General Information
Number of Employees: 20,300 (As of 6/30/2024)
Outstanding Shares: 11,695,881,732 (As of 10/15/2024)
Shareholders: 8,700
Stock Exchange: HKG
Fax Number: +86 31187039608


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024